Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and the Safety of Granulocyte Colony-stimulating Factor Treatment in Children and Adolescents With Muscular Dystrophy: An Open Study

NCT02814110 is registered in ClinicalTrials.gov with Medical University of Bialystok as lead sponsor.

NCT NCT02814110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02814110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and the Safety of Granulocyte Colony-stimulating Factor Treatment in Children and Adolescents With Muscular Dystrophy: An Open Study
Lead sponsor
Medical University of Bialystok
Phase
Phase 1
Overall status
Unknown status
Start date
March 1, 2013
Completion date
December 31, 2022
Enrollment
27 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

increase muscle strength in patients with muscular dystrophy